Neurable develops wearable devices designed to monitor focus and cognitive workload, targeting both individual users and enterprise customers. According to the company, the technology can be applied to knowledge work, sports, and safety- and performance-critical environments, where lapses in concentration can have real-world consequences.
The new $35 million funding round will be used to further develop Neurable’s platform, which combines EEG sensors with AI algorithms capable of analyzing brain signals in real time. The company focuses on solutions that do not require implants, setting it apart from some competitors and significantly lowering regulatory and clinical barriers.
Neurable emphasizes the central role of AI in filtering EEG noise and extracting meaningful neural patterns—a challenge that has long slowed the commercialization of BCI technologies. The new capital will support continued research as well as the expansion of engineering and product teams.
Before this latest round, Neurable had raised more than $15 million, bringing its total funding to over $50 million. Growing investor interest in BCI startups is closely tied to advances in AI and increasing demand for brain health monitoring technologies, although experts continue to point out significant scientific and regulatory hurdles.
Neurable says its next phase will focus on commercial scaling and bringing products to market, while maintaining close collaboration with research institutions. The company has not yet disclosed a timeline for upcoming launches, but states that the new funding will significantly shorten the path from prototypes to real-world deployments.